Floatz logo

10 assets in Pediatric Hepatocellular Carcinoma

Therapeutic assets addressing Pediatric Hepatocellular Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fluorouracilum
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3BB (66)
Sorafenib
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3BB (64)
Oxaliplatin
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3B (62)
Adriamycin
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Carboplatin
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Cis-Diamminedichloroplatinum Ii
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Etoposide
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Irinotecan
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Vincristine Sulfate
Pediatric Hepatocellular Carcinoma
Children's Oncology GroupP3B (60)
Pembrolizumab
Pediatric Hepatocellular Carcinoma
Allison O'Neill, MDP2CCC (53)